Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients by Kreisel, W et al.
ORIGINAL ARTICLE
Endoscopic diagnosis of acute intestinal GVHD following allogeneic
hematopoietic SCT: a retrospective analysis in 175 patients
W Kreisel
1, M Dahlberg
1, H Bertz
2, J Harder
3, K Potthoff
4, P Deibert
5, A Schmitt-Graeff
6 and J Finke
2
1Department of Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, University Hospital Freiburg,
Freiburg, Germany;
2Department of Haematology and Oncology, University Hospital Freiburg, Freiburg, Germany;
3Hegau-Bodensee-Kliniken, Singen, Germany;
4Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany;
5Department of Rehabilitative and Preventive Sports Medicine, University Hospital Freiburg, Freiburg, Germany and
6Department of Pathology, University Hospital Freiburg, Freiburg, Germany
Diagnosis of acute intestinal GVHD (aGVHD) following
allogeneic hematopoietic cell transplantation is based
on clinical symptoms and histological lesions. This retro-
spective analysis aimed to validate the ‘Freiburg Criteria’
for the endoscopic grading of intestinal aGVHD. Grade 1:
no clear-cut criteria; grade 2: spotted erythema; grade 3:
aphthous lesions; and grade 4: conﬂuent defects, ulcers,
denudation of the mucosa. Having excluded patients with
infectious diarrhea, we evaluated 175 consecutive patients
between January 2001 and June 2009. Setting a cutoff
between grade 1 (no change in therapy) and grade
2 (intensiﬁcation of immunosuppression), macroscopy
had a sensitivity of 89.2% (95% conﬁdence interval
(CI): 80.4–94.9%), a speciﬁcity of 79.4% (95% CI: 69.6–
87.1%), a positive-predictive value of 79.6% (95% CI:
70.0–87.2%) and a negative-predictive value of 89.0%
(95% CI: 80.2–94.9%). In all, 20% of patients with
aGVHD in the lower gastrointestinal tract (GIT) had
lesions only in the terminal ileum. In all patients with
aGVHD X2 of the upper GIT, typical lesions were also
found in the lower GIT. Ileo-colonoscopy showed
the highest diagnostic yield for aGVHD. In conclusion,
the ‘Freiburg Criteria’ for macroscopic diagnosis of
intestinal aGVHD provide high accuracy for identifying
aGVHD X2.
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Introduction
Allogeneic hematopoietic SCT has become an essential part
of the standard therapeutic repertoire in several hematolo-
gical diseases, such as acute or chronic leukemias, other
hematological malignancies, inborn metabolic errors and
conditions of BM failure.
1–7 Frequent complications
are infections, side effects from the conditioning regime
or medications, and GVHD with skin, gut or bile ducts, as
its the main organ manifestations. For historical rather
than clinical or pathophysiological reasons, GVHD has
been categorized in acute GVHD, arising before day
þ100 after transplantation, and chronic GVHD, arising
later than day þ100.
8–11 However, this strict differentia-
tion has been abandoned. A condition which arises after
day þ100 after SCT and shows the clinical features of the
classical acute intestinal GVHD (aGVHD) is regarded as a
late-onset aGVHD.
12–14 Acute GVHD affects mainly the
skin, liver and gastrointestinal tract (GIT).
15–18 Leading
symptoms are rash or erythema, jaundice, diarrhea and
nausea. In late chronic GVHD, the symptoms gradually
evolve into a scleroderma-like syndrome.
19–22 Gold stan-
dard for diagnosis is histology (skin, liver, gut), and there
are long-established criteria for its histological diagnosis
and grading. The most important signs of intestinal
aGVHD are crypt cell apoptosis and the presence of crypt
loss.
12,23,24 However, before day þ20 after SCT, similar
lesions can also be caused by the conditioning regime
itself.
24 The grading of intestinal aGVHD has been
suggested to fall between 1 and 4 according to the degree
of histological characteristics. It is generally accepted that
for a correct diagnosis of intestinal GVHD, biopsies from
the GIT must be obtained. Clinical experience has shown
that histologically proven intestinal aGVHD X2 reﬂects
clinically evident intestinal aGVHD X2 very well, and is
therefore a clear indication for intensifying immuno-
suppressive therapy.
25
Diarrhea after SCT is an ambiguous symptom. Its main
causes are drug-induced side effects, chemotherapy or
radiation-induced toxicity, infections and GVHD.
26,27
Microbiological investigation is the ﬁrst step in the
diagnostic work-up in such patients. The presence of
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www.nature.com/bmtthrombocytopenia often prevents endoscopy with biopsies,
and hematologists were long reluctant to do colonoscopies
in these patients because of worries about complications
associated with invasive procedures and the ambiguous
diagnostic yield. Our paper published in 1994 was the ﬁrst
systematic survey to evaluate the macroscopic ﬁndings
obtained during colonoscopy and compare them with
histology. Our criteria for the endoscopic diagnosis of
aGVHD of the lower GIT compared well with histological
ﬁndings.
28 Later on, other authors used slightly different
endoscopic criteria for diagnosing intestinal aGVHD
grades 1–4. However, these studies could not establish
such a simple stepwise grading system from macroscopic
ﬁndings (grades 1–4), which readily parallel with histolo-
gical grades (1–4).
14,29–33 Therefore, these criteria cannot be
easily used for immediately predicting whether or not an
aGVHD grade X2 exists. Thompson et al.
31 used our
grading system in a relatively small cohort of 24 patients,
ﬁnding some correlation between histological and clinical
data, but their data were insufﬁcient to guide the clinician
to a therapeutic decision.
In this paper, we present a retrospective analysis of our
endoscopic data, in which to our knowledge is the largest
cohort of patients after Allo-SCT. From a clinical point
of view, it is sufﬁcient to deﬁne whether an aGVHD X2
exists, because this diagnosis requires intensive immuno-
suppression. Accordingly, we have slightly modiﬁed our
original criteria: we have now decided against deﬁning
grade 1 criteria, because this diagnosis is doubtful and does
not lead to a change in therapy. The primary aim of this
study was to investigate whether diagnosis of histological
aGVHD X2 can be based on the macroscopic ﬁndings in
the colon and terminal ileum conﬁrming the validity of
the endoscopic ‘Freiburg Criteria’. Therefore, we compared
them with histology, which is and remains the gold
standard for diagnosis. In addition, we evaluated the
distribution of aGVHD lesions along the GIT in order to
get information about the best endoscopic diagnostic
approach.
Patients and methods
Patients
Allogeneic hematopoietic cell transplantation was performed
in 751 patients in our department between January 2001 and
June 2009. Colonoscopy was performed in 215 patients
because of suspected aGVHD. The indication for endo-
scopy was diarrhea, nausea, vomiting or other GIT symptoms.
Microbiological tests were performed immediately if aGVHD
was suspected, endoscopies were performed one (or two)
day(s) later. Patients are prepared for colonoscopy with a
PEG-containing solution. In all, 175 consecutive patients
could be included into this study, who had both endoscopic
and histological ﬁndings available, were at least 20 days post
allogeneic hematopoietic cell transplantation and did not have
an infectious process identiﬁed. In all, 56% of the 175 patients
were male, 44% were female. Mean age was 53 years, s.d.
13 years. The underlying diseases were AML (43%), myelodys-
plastic syndrome (MDS) (14%), ALL (10%), non-Hodgkin
lymphoma (NHL) (10%), CLL (9%), CML (4%), other
myeloproliferative syndrome (MPS) (4%), malignant mel-
anoma (MM) (3%) and others (3%).
The conditioning regimes were combinations consisting
of ﬂudarabine, BU, cyclophosphamid, BCNU (carmus-
tine), melphalan, thiotepa, treosulfan, etoposide (VP16) or
TBI. For prophylaxis of aGVHD the following drugs were
used: CsA, alemtuzumab, mycophenolate mofetil, MTX
and ATG.
Endoscopy
We compared the macroscopic and histological ﬁndings in
175 patients in whom a concomitant intestinal infection
had been excluded. If the same patient had had several
colonoscopies, we only evaluated the ﬁrst one. During the
ﬁrst year of the study, we only aimed to perform an
inspection of the total colon and we did an ileoscopy only
in part of the cases. Only later, we perceived that in several
patients typical aGVHD lesions can be found only in the
terminal ileum. Therefore, the terminal ileum was intubated
during the colonoscopy in only 74 patients. Forty-one
patients underwent both gastroscopy and colonoscopy, and
biopsies could be obtained in all of them. Colonoscopies
and/or gastroscopies were performed by experienced
endoscopists using Olympus endoscopes (CF 130 L, CF
140 I, CF Q 145 AI, CF-H 180 AI, GIF Q 145, GIF Q 165,
GIF H 180, Olympus, Hamburg, Germany). All macro-
scopic ﬁndings were evaluated according to the ‘Freiburg
Criteria’. The endoscopists recorded their interpretation
immediately after the endoscopies. Later on, all pictures
and interpretations were cross-checked by WK.
Biopsies were taken from different sites in the GIT: at
least one biopsy was taken in the ascending, transverse and
descending colon, and in the rectosigmoid. In 56 cases,
biopsies were taken from the terminal ileum. Biopsies were
stained using hematoxylin–eosin and evaluated using the
latest criteria for histological diagnosis of aGVHD,
12 which
are indicated in Table 1 in the Results section. The presence
of CMV infection was excluded by staining for CMV Ag.
Histological specimens were mainly evaluated by ASG. All
participating pathologists used the same criteria for
histological grading.
12
Macroscopic criteria for aGVHD (‘Freiburg Criteria’)
The criteria for diagnosing and grading intestinal aGVHD
(‘Freiburg Criteria’) are indicated in Table 2. The
differences to our original criteria from 1994 are slight.
28
The macroscopic diagnosis of aGVHD grade 1 is ambig-
uous and the consequences of no aGVHD and aGVHD
grade 1 are the same, namely, no change in therapy. We
Table 1 Deﬁnition and histological grading system for gastro-
intestinal aGVHD
12
Grade Histological feature
1 Isolated apoptotic epithelial cells without crypt loss
2 Loss of isolated crypts without the loss of contiguous crypts
3 Loss of 2 or more contiguous crypts
4 Extensive crypt loss with mucosal denudation
Abbreviation: aGVHD¼acute intestinal GVHD.
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described lesions typical for the grades 2–4. If there
were no grade X2 lesions, we state only that there is no
aGVHD X2. This should lead the clinician to decide
against changing the actual therapy. If an aGVHD X2
was diagnosed, it was an indicator to the clinician that
immunosuppressive therapy should be intensiﬁed.
We draw attention to the fact that these criteria primarily
refer to the lesions in the terminal ileum and colon only.
Comparison between histology and macroscopy refers to
terminal ileum and colon as well. However, for evaluating
the diagnostic accuracy of upper and lower GIT endoscopy
only histological ﬁndings were compared.
Results
Time interval after SCT
The time after SCT is shown in Figure 1. Endoscopies were
performed between days þ21 and þ405. Endoscopies
were performed before day þ100 in 65%, after day þ100
in 35%.
Histological and macroscopic grading of aGVHD
Histological grading of intestinal aGVHD. The criteria for
the histological grading of intestinal aGVHD according to
Washington et al.
12 are indicated in Table 1. Figure 2 shows
examples of the grades of aGVHD from grades 1 to 4.
Macroscopic grading of intestinal aGVHD. The criteria
for grading gastrointestinal aGVHD macroscopically
(‘Freiburg Criteria’) in the terminal ileum and the colon
are indicated in Table 2. Figure 3 illustrates macroscopic
examples of aGVHD from grades 2 to 4.
Comparison of macroscopy and microscopy. Table 3
contains a survey of the endoscopic and histological
grading data and the comparison between macroscopic
and histological grading of aGVHD in the terminal ileum
and colon in the 175 ileo-colonoscopies.
Macroscopy and histology were graded identically in
71%, and in 18% there was a difference of ±1 grade. We
observed a difference of more than 2 grades in only 11%.
Table 4 indicates sensitivities and speciﬁcities of the
macroscopic criteria in comparison with histology, which
is used as the gold standard. It indicates the calculation
using a cutoff between grades 1 and 2 for macroscopy and
histology. The cutoff value between histological grades 1
and 2 reﬂects the cutoff for the decision whether to start
immunosuppressive therapy or not. Table 4 also explains
the calculation using a cutoff between grades 2 and 3 for
macroscopy, and between grades 1 and 2 for histology. In
practice, macroscopic grade 3 aGVHD is easier to diagnose
than grade 2. As expected, the cutoff between grades 1 and
2 yields high sensitivity and a little less speciﬁcity. When the
cutoff is set between grades 2 and 3, a little sensitivity is lost
but the speciﬁcity increases.
If we keep the cutoff between histology at grades 1 and
grade 2, vary the cutoff for the macroscopy and calculate
the ROC, the Youden index (sensitivityþspeciﬁcity–1) is as
follows: 0.685 for cutoff 1/2, 0.665 for cutoff 2/3, and 0.572
for cutoff 3/4. Therefore, in order to achieve a diagnostic
endoscopic procedure with the highest sensitivity and
speciﬁcity by setting the cutoff between grades 1 and
2 seems optimal for both histology and macroscopy.
Involvement of different parts of the GIT in aGVHD
Distribution of aGVHD in the GIT. As shown in Figure 4,
the different grades of aGVHD are unevenly distributed in
the GIT. Remarkably, the frequency of grade 4 aGVHD in
the terminal ileum or duodenum was 54% and 33.3%,
respectively, whereas grade 4 aGVHD occurred in only
18.4% of the total cohort of patients with colonoscopy
(without or with ileoscopy). These data suggest that the
small bowel shows grade 4 involvement more frequently
than does the colon, and that the terminal ileum may be
affected by this disease without the involvement of colon.
However, it is important to remember that these data were
collected in a selected subset of the 175 patients and that
they do not necessarily reﬂect the true distribution.
Is ileoscopy necessary in colonoscopy? The terminal ileum
was inspected on colonoscopy in 74 patients, and we could
evaluate histological grading in 56 patients with acute GVHD
grade X1. In all, 39 patients (69.9%) had aGVHD grade X2.
Overall, 13 had these lesions in the colon only, 18 in the colon
and terminal ileum. In 8 patients (20%) with aGVHD X2t h e
terminal ileum was involved exclusively and the colon was
normal (Figure 5a). This demonstrates that the terminal
ileum should be inspected whenever possible.
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Figure 1 Time interval between SCT and endoscopy.
Table 2 Macroscopic grading of aGVHD in the terminal ileum
and colon: the ‘Freiburg Criteria’ for macroscopic diagnosis of
intestinal aGVHD
Grade 1 No clear-cut criteria! It sufﬁces to state that there is no
GVHD grade X2
Cutoff between watch-and-wait and immediate therapy
Grade 2 Spotted erythema, initial aphthous lesions
Grade 3 Aphthous lesions (Crohn-like) or focal erosions
Grade 4 Conﬂuent defects, ulcerations, complete denudation of
the mucosa
Abbreviation: aGVHD¼acute intestinal GVHD.
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Bone Marrow TransplantationUpper and/or lower GIT endoscopy. Endoscopies of the
upper and lower GIT at the same time point were
performed in 41 patients. Figure 5b shows that histological
aGVHD X2 lesions were never identiﬁed solely in the
upper GIT and not in the lower GIT, when including the
terminal ileum. These data suggest that a colonoscopy
including inspection of the terminal ileum has the highest
diagnostic yield, which is not increased by additional upper
GIT endoscopy.
In a small subset of 15 out of these 41 patients, histology
in rectum sigmoid colon, other parts of the colon, terminal
ileum, stomach and duodenum could be evaluated at the
same time (Table 5). In all 15 patients we found histological
grade X1 aGVHD in at least one region of the GIT and
grade X2 aGVHD in 12 of them likewise in at least one
part of the GIT. Table 5 illustrates the diagnostic accuracy
of histological evaluation of different parts of the GIT
and combination of endoscopies if one evaluates these
15 patients. Inspection of rectum and sigmoid colon found
aGVHD X2 in 7/12 patients, inspection of the total colon
yielded the correct diagnosis in 10/12 patients. The yield of
colonoscopy with ileoscopy for diagnosing aGVHD X2
amounts to 100% (12/12 patients). These data suggest that
an ileoscopy detects aGVHD requiring therapy in several
patients with normal ﬁndings in the colon. However,
the combination of recto-sigmoidoscopy and esophago-
gastro-duodenoscopy (including histology in the duodenum)
may be equivalent. Alternatively: An esophago-gastro-
duodenoscopy yielded no further information if ileo-
colonoscopy has been done.
aGvHD 1 aGvHD 1
aGvHD 2 aGvHD 2
aGvHD 3 aGvHD 3
aGvHD 4 aGvHD 4
Figure 2 Histological ﬁndings in different grades of intestinal aGVHD. Apoptotic crypt cell loss (grade 1) or loss of single crypts (grade 2) are marked by
arrows. Grade 3: loss of contiguous crypts (white ellipse). Grade 4: complete denudation of the mucosa.
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To our knowledge this is by far the largest study addressing
the diagnostic value of endoscopic and macroscopic
diagnosis of intestinal aGVHD. We demonstrate that
using the modiﬁed ‘Freiburg Criteria’ in ileo-colonoscopy,
macroscopy has high sensitivity and speciﬁcity for diagnos-
ing aGVHD X2 and it can therefore guide the clinician to a
aGvHD 2
Spotted
erythema
aGvHD 3
Aphthous
lesions 
aGvHD 4
Figure 3 (a) Examples for macroscopic grading of aGVHD as grade 2. (b) Examples for macroscopic grading of aGVHD as grade 3. (c) Examples for
macroscopic grading of aGVHD as grade 4: Conﬂuent defects, ulcerations and complete denudation of the mucosa. The white ﬂap is sloughed mucosa.
Table 3 Comparison of macroscopy and histology of aGVHD in
the terminal ileum and colon
Grade 0–1 2 3 4 Macroscopy
0–1 73 7 7 5 92
2 7 523 1 7
31 1 1 0 1 2 2 4
4 1 2 2 37 42
Histology 82 15 21 57 175
Abbreviation: aGVHD¼acute intestinal GVHD.
Table 4 Comparison of macroscopy and histology in 175
colonoscopies applying two different cutoff values
Macroscopy X2v s
histology X2
Macroscopy X3v s
histology X2
N (%) 95% CI N (%) 95% CI
Sensitivity 74/83 (89.2) 80.4–94.9% 66/83 (79.5) 69.2–87.6%
Speciﬁcity 73/92 (79.4) 69.6–87.1% 80/92 (87.0) 78.3–93.1%
PPV 74/93 (79.6) 70.0–87.2% 66/78 (84.6) 74.7–91.8%
NPV 73/82 (89.0) 80.2–94.9% 80/97 (82.5) 73.4–89.5%
Abbreviations: CI¼conﬁdence interval; NPV¼negative-predictive value;
PPV¼positive-predictive value.
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Figure 4 Distribution of different grades of aGVHD in the gastrointest-
inal tract. Frequency of histological grading of intestinal aGVHD in the
different parts of the gastrointestinal tract. Term. ileum, terminal ileum.
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Bone Marrow Transplantationrapid therapeutic decision. In this evaluation, we set a
cutoff for macroscopy and histology between aGVHD
grades 1 and 2, because it is generally accepted that a
histologically diagnosed intestinal aGVHD X2i sa n
indication for intensifying immunosuppressive therapy.
In contrast to our earlier paper,
28 we have refrained from
deﬁning the macroscopic criteria for aGVHD grade 1. The
rationale behind that decision was that its potential signs
are ambiguous, and the only clinical consequence is not to
change the therapy. Therefore, only the differentiation
between grades 0–1 (no change in therapy) and grade X2i s
clinically relevant. Beginning from grade 2 there is a
stepwise progression of macroscopic lesions from spotted
erythema (‘initial aphthous lesions’; grade 2) to ‘complete
denudation of the mucosa’ (grade 4), which parallels the
stepwise progression of the histological lesions. Our data
thus suggest that applying the ‘Freiburg Criteria’ in ileo-
colonoscopy could be an important tool for the clinician in
making a therapeutic decision. The decision not to change
therapy or to intensify immunosuppression can be made
immediately using these macroscopic criteria, whereas
histology would delay the change in therapy by at least
1 day.
Our study included patients with an endoscopy between
days þ20 and 405 after SCT. The classical differentiation
between GVHD arising before day 100 (acute GVHD)
and after day 100 (chronic GVHD) has meanwhile
been abandoned.
12–14 In particular, the use of less
intensity-conditioning regimes led to a late occurrence of
a clinical situation that is classiﬁed as ‘delayed acute
GVHD’ with no difference to the ‘classical acute GVHD’.
Alternatively, persistent acute GVHD is found after day
þ100. Endoscopic ﬁndings from patients were therefore
included in our study if they presented with the classical
clinical symptoms of acute GVHD (gut, liver, skin) without
clinical manifestations suggesting cGVHD.
Several studies have evaluated the diagnostic yield of
macroscopic aspects of endoscopy in comparison with
histology. The ﬁrst study was our own paper from 1994,
28
in which we described the high sensitivity and speciﬁcity
of macroscopy compared with histology in the recto-
sigmoidoscopies of 42 patients after allogeneic BMT. In a
cohort of 44 patients, Cruz-Correa et al.
32 described slightly
different criteria for macroscopic diagnosis. Combining
ﬁndings in patients with all grades of aGVHD (grades 1–4)
and combining their ﬁndings in the lower and upper GIT,
they reported a sensitivity of 83% (10/12), a speciﬁcity of
69% (22/32), a positive-predictive value of 50% (10/20) and
a negative-predictive value of 92% (22/24). However,
because of the mixture of upper and lower GIT ﬁndings,
it is difﬁcult to translate their data into clear-cut
therapeutic recommendations for the clinician. The authors
reported no data about ﬁndings in the terminal ileum.
Cheung et al.
30 used the Cruz-Correa criteria, focussing on
sigmoidoscopy and gastroscopy, and concluding that the
overall reliability of the endoscopic diagnosis of aGVHD
remains inadequate. Thompson et al.
31 used the macro-
scopic criteria we described. However, they observed little
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Figure 5 Diagnostic yield of histology of different parts of the gastrointestinal tract. (a) Only colonoscopy vs colonoscopyþileoscopy. Number of patients
with histologically proven aGVHD X1 in: only colon; colon and terminal ileum; and only terminal ileum. Number of patients with histologically proven
aGVHD X2 in: only colon; colon and terminal ileum; only terminal ileum. (b) Ileo-colonoscopy vs upper GIT endoscopy vs combination of both. Number
of patients with histologically proven aGVHD X1 in: only lower GIT; lower and upper GIT; and only upper GIT. Number of patients with histologically
proven aGVHD X2 in: only lower GIT; lower and upper GIT; and only upper GIT. Term. ileum, terminal ileum.
Table 5 Diagnostic accuracy of endoscopy of different parts of the gastrointestinal tract
Endoscopy Histological aGVHD X1 Histological aGVHD X2
n % 95% CI n % 95% CI
EGD 12 80 60–100 8 67 40–93
Sigmoidoscopy 12 80 60–100 7 58 30–86
Colonoscopy 13 87 69–103 10 83 62–104
Colonoscopy with intubated terminal ileum 13 87 69–103 12 100 100–100
EGD+sigmoidoscopy 14 93 81–106 11 92 76–107
Total 15 12
Abbreviations: aGVHD¼acute intestinal GVHD; CI¼conﬁdence interval; EGD¼esophagogastroduodenoscopy.
In a small subset of 15 patients, histology of EGD, recto-sigmoidoscopy, colonoscopy and ileo-colonoscopy could be evaluated and histology showed grade
X1 aGVHD in at least one site. In 12 of these 15 patients, histology showed grade X2 aGVHD in at least one site. This table indicates the diagnostic
accuracy of different endoscopic examinations.
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Bone Marrow Transplantationconcordance between macroscopic and histological ﬁndings
(38.9%) with a difference of 2–4 grades between macro-
scopy and histology in 28.2%, focussing on the diagnostic
yield of biopsies in different parts of the lower and upper
GIT for diagnosing all grades of aGVHD. In a small cohort
of 24 patients with suspected aGVHD, they found a
diagnostic yield of histology in the distal colon of 82%, and
nearly identical data for upper GIT endoscopyþsigmoido-
scopy and colonoscopyþileal biopsies (about 94%). There
is an important difference between our study and the data
of Thompson: Thompson et al. focussed on the presence of
aGVHD of any grade (that is, grade 1–4) and they did not
differentiate between grade 1—without clinical conse-
quences—and higher grades—with clinical consequence of
intensiﬁcation of immunosuppression. They reported a
high rate of aGVHD of 44.7% even in endoscopically
normally appearing regions. This can be explained by the
fact that there are no reliable macroscopic signs of grade 1
aGVHD (we neglected a possible grade 1 aGVHD as
mentioned above!) and that macroscopic grade 4 aGVHD
in the terminal ileum is difﬁcult to discriminate from grade
0 to 1. Ross et al.
14 reported a higher diagnostic accuracy of
biopsies in the rectosigmoid colon than in the upper GIT.
However, their data cannot be compared with ours,
because the authors did not perform total ileo-colonosco-
pies and they did not differentiate between grade 1 aGVHD
and grades 2–4. They performed esophago-gastro-duode-
noscopy and recto-sigmoidoscopy. If histological criteria
of aGVHD at least grade 1 were fulﬁlled, the patient
was classiﬁed as having aGVHD. In this setting, recto-
sigmoidoscopy had the highest sensitivity and speciﬁcity.
On contrast, we did a complete colonoscopy and in part of
the patients ileo-colonoscopy and we focus on patients with
aGVHD X2 (requiring start or intensiﬁcation of therapy).
In this setting, we found that in about 20% of the patients
with ileo-colonoscopy typical aGVHD lesions could be
found only in the terminal ileum that would have been
missed if only recto-sigmoidoscopy was performed. Apart
from that: it was not only a primary aim of our study to
describe the occurrence of aGVHD along the GIT but also
to evaluate macroscopic criteria that ﬁt very well to the
histological classiﬁcation. However, the observation of an
isolated manifestation of aGVHD in the terminal ileum is
clinically relevant and should be evaluated in a prospective
study.
The high diagnostic accuracy described in our study may
be due to several reasons: (1) our group has over 15 years of
experience with endoscopy in GVHD patients, and all of
these endoscopies have been supervised or double-checked
by the investigator with the greatest expertise (WK).
(2) The evaluation of macroscopic results focuses on grade
X2 lesions which reveal alterations that can easily be
diagnosed (grade 3 lesions are the most distinct lesions!).
(3) Comparison between macroscopy and histology
concerns only ileo-colonoscopic ﬁndings and not those
of gastro-duodenoscopy, because experience has shown us
that it is difﬁcult to transfer our criteria to lesions found
in the upper GIT. (4) It should be considered in all com-
parisons between macroscopy and histology that histological
lesions in aGVHD of the stomach or even duodenum are
less well deﬁned than in the lower GIT.
12,14,33,34
An important aspect of endoscopy in aGVHD patients is
the potential similarity between lesions in the GIT due to
aGVHD and gastrointestinal infections.
35,36 For our ﬁnal
evaluation we eliminated 19 patients with CMV infection
or cryptosporidia. CMV infection in particular may mimic
all grades of aGVHD. However, clinically speaking, this
fact hardly interferes with the endoscopic diagnosis of
aGVHD. After onset of diarrhea as the leading symptom,
the ﬁrst diagnostic measure is the microbiological examina-
tion of stool, followed by endoscopy 1 or 2 days later.
Thus, the microbiological results are already available
when endoscopy is performed.
In this paper, we show data on the distribution
of histological lesions of aGVHD along the GIT and its
diagnostic implications, observing clinically important
results: (1) aGVHD grade 4 is the most frequent type of
involvement in aGVHD in the small bowel (meaning the
duodenum or terminal ileum), (2) in about 20% of cases of
gastrointestinal aGVHD grade X2 in the lower GIT,
lesions were detected during ileo-colonoscopy only in the
terminal ileum and not in the colon. Therefore, if an
aGVHD is suspected because of clinical symptoms,
the terminal ileum must be inspected if the colon is free
of typical lesions, and (3) if the terminal ileum can
be examined during colonoscopy, gastro-duodenoscopy
yields no additional information. These results lead us to
conclude that the duodenum and terminal ileum behave in
parallel when affected by aGVHD. A combination of recto-
sigmoidoscopy and gastro-duodenoscopy has nearly the
same diagnostic yield (92%) as colonoscopy in conjunction
with inspection of the terminal ileum (100%). Nevertheless,
it is essential to conﬁrm the data by a prospective study in a
larger cohort.
We are aware the fact that our study has all the
limitations of a retrospective analysis. Nevertheless, the
good correlation between the macroscopic and the histo-
logical grading has a solid base. Histological criteria
are generally accepted, our macroscopic criteria have been
deﬁned before the evaluation (there was only a slight
modiﬁcation of the criteria established by ourselves in
1994), and macroscopic and histological feature could
be compared in the same region of the affected gut. It may
be a shortcoming that the number of biopsies taken during
the endoscopy was relatively small. This may have led to
underestimation of the histological degree of aGVHD.
However, there is a good correlation between macroscopic
and histological grading. We do not intend to discourage
hematologists or gastroenterologists to take biopsies.
On the contrary, we are supporting the conclusions already
drawn by Ponec et al.
37 According to them endoscopy and
histology are complementary. And considering that histol-
ogy itself has got some limitations, endoscopy can give an
important contribution for diagnosis ﬁnding.
It may be argued due to the relatively high prevalence of
higher-grade endoscopic lesions in our patients that we
evaluated patients with a more progressed aGVHD than
other authors did. One could divide the group of patients
into those with early or late or very late aGVHD. But this is
beyond the scope of the manuscript, which describes and
evaluates macroscopic ﬁndings and correlates them with
histology. Differentiation of patients in different groups
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without gain of additional information.
Conclusion
The macroscopic aspect of the GIT, in particular the
lower GIT, has high validity for diagnosing intestinal
aGVHD. Using the ‘Freiburg Criteria’ in ileo-colonoscopy
macroscopy facilitates the differentiation between no
aGVHD or mild grade 1 aGVHD, and the higher grades
X2, which require intensiﬁcation of immunosuppression.
We suggest the following approach in suspected intestinal
aGVHD: if intestinal aGVHD is suspected due to diarrhea
a stool specimen should be tested for intestinal pathogens
(including Clostridium difﬁcile, CMV and cryptosporidia)
as soon as possible. The patient should be prepared for
colonoscopy, which will be performed the next day. Ideally,
the microbial results are available when colonoscopy is
performed. If the macroscopic aspect of the colon is typical
for aGVHD X2, an ileoscopy need not been done. If the
colon appears macroscopically normal the terminal ileum
must be inspected. An endoscopic examination of the
upper GIT may then be omitted. Nevertheless, biopsies
should be taken if ever possible to conﬁrm the macroscopic
diagnosis and immunostaining for CMV should be
considered.
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